Mozambique

All of the nearly 28 million people living in Mozambique are at risk for at least one neglected tropical disease (NTD). The country is endemic for all five NTDs targeted by USAID’s Act to End Neglected Tropical Diseases | East program: lymphatic filariasis (LF), onchocerciasis, trachoma, schistosomiasis, and soil-transmitted helminth infections.
 

Since 2012, USAID has supported Mozambique’s Ministry of Health (MOH) to reach its NTD control and elimination goals by focusing on the scale up of mass treatment for trachoma and by providing central-level support for the program management of all endemic NTDs. As a result, a major portion of the population is no longer at risk for trachoma, and the country is on track to eliminate the disease by 2023.

Our Focus

Act | East is implemented in Mozambique by RTI International. The program continues USAID’s focus on the elimination of trachoma from the country, through support for mass drug administration campaigns, impact surveys, and dossier development.